Migraines & headaches decisions — 2025

The Board remands the claims for service connection for obstructive sleep apnea, traumatic brain injury (TBI), seizures, neurocognitive disorder, and headache disorder to obtain a new VA examination and opinion.

The Board denied increased ratings for PTSD, migraines, GERD, hypothyroidism, and hemorrhoids but granted a 70 percent rating for PTSD from April 15, 2019.

The Board granted a separate 30 percent disability rating for homonymous hemianopsia and a 50 percent disability rating for migraine headaches, while denying an increased rating for hypertension. The Veteran was also granted a total disability rating based on individual unemployability.

The Veteran's migraine headaches were granted a rating of 30 percent prior to August 1, 2023, and the claim for a rating in excess of 50 percent was denied from that date onward. The TDIU claim was also denied.

The Board granted a 10 percent initial rating for the Veteran's headache condition prior to November 12, 2020. The left knee condition issue was remanded for further development.

The Board denied an increased disability rating for migraines and plantar warts, finding that the current ratings accurately reflect the severity of these conditions.

The Board denied service connection for a disability manifested by shortness of breath and remanded claims for dizziness, headache disorder, right lower extremity polyneuropathy, and left lower extremity polyneuropathy.

The appeal was dismissed due to the death of the appellant and no eligible person has been identified for substitution.

The Board denied the veteran's claims for increased ratings for adjustment disorder, GERD, migraines, and syncope disorder due to her failure to report for scheduled VA examinations without good cause.

The Board denied service connection for chronic fatigue syndrome and a compensable disability rating for irritable bowel syndrome, while remanding the issue of a higher rating for migraine headaches.

The Board granted a rating of 30 percent for the Veteran's tension headaches, finding that they occur on an average once a month and are prostrating in nature.

The Board denied the veteran's request for an earlier effective date for the increased ratings of 30 percent for migraine headaches and 10 percent for right foot plantar fasciitis, as no formal claim or written intent to file a claim was received prior to May 28, 2024.

The Board denied service connection for hearing loss and a headache disorder, to include migraines. The appeal as to the issue of entitlement to service connection for tinnitus was dismissed, and other claims were remanded.

The Board denied service connection for hair loss and headaches as there was no evidence of a current disability related to these conditions that could be linked to the Veteran's active service.

The Board denied the veteran's claims for service connection and increased ratings due to his failure to report for necessary VA examinations.

The Board granted service connection for a left ankle condition and a left shoulder condition, but denied service connection for bilateral hearing loss. The claims for allergic rhinitis, RLS, CFS, IBS, respiratory dyspnea, chronic headaches, and an increased rating for the psychiatric condition were remanded.

The Board granted an increased initial disability rating of 50 percent for migraine headaches, denied a higher initial disability rating for fibromyalgia and PTSD, and denied earlier effective dates for service connection for these conditions.

The Board remands the claim for a refund of a VA funding fee to obtain additional records and readjudicate the decision with consideration that the Veteran was still on active duty and receiving service pay at the time of the closing of his home loan.

The Board granted service connection for generalized anxiety disorder, persistent depressive disorder, sinusitis, and tinnitus. A 10 percent rating was granted for chronic headaches from December 22, 2021.

The Board granted a 10 percent evaluation for the Veteran's pilonidal cyst with abscess but denied a 50 percent evaluation for her migraine headaches before September 12, 2024.